Revive Rx LLC dba Revive Rx Pharmacy
FDA Regulatory Profile
Summary
- Total Recalls
- 3 (2 Class I)
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|
| D-0511-2024 | Class I | Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Produ | April 20, 2024 |
| D-0771-2023 | Class II | Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Pr | May 11, 2023 |
| D-0648-2022 | Class I | HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, | February 11, 2022 |